Yinghong Zhu

ORCID: 0000-0002-9987-073X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Myeloma Research and Treatments
  • Liver Disease Diagnosis and Treatment
  • Gut microbiota and health
  • Cardiovascular Function and Risk Factors
  • Cancer therapeutics and mechanisms
  • Atherosclerosis and Cardiovascular Diseases
  • Drug Transport and Resistance Mechanisms
  • Cardiac Fibrosis and Remodeling
  • Histone Deacetylase Inhibitors Research
  • Peroxisome Proliferator-Activated Receptors
  • Protein Degradation and Inhibitors
  • Diet, Metabolism, and Disease
  • Lipid metabolism and disorders
  • Cancer, Lipids, and Metabolism
  • Parasitic Infections and Diagnostics
  • Pharmacological Effects of Natural Compounds
  • Signaling Pathways in Disease
  • Cholesterol and Lipid Metabolism
  • NF-κB Signaling Pathways
  • Peptidase Inhibition and Analysis
  • Oral and gingival health research
  • Pluripotent Stem Cells Research
  • Ubiquitin and proteasome pathways
  • Photodynamic Therapy Research Studies
  • Metabolism, Diabetes, and Cancer

Central South University
2018-2025

Ministry of Education of the People's Republic of China
2022-2025

Third Affiliated Hospital of Guangzhou Medical University
2020-2024

Guangzhou Medical University
2020-2024

Xiangya Hospital Central South University
2019-2023

Osaka University
2015-2023

University of Arkansas for Medical Sciences
2023

Cleveland Clinic Lerner College of Medicine
2023

National Health and Family Planning Commission
2018-2022

Hunan Cancer Hospital
2020-2021

Abstract Background Gut microbiome alterations are closely related to human health and linked a variety of diseases. Although great efforts have been made understand the risk factors for multiple myeloma (MM), little is known about role gut its metabolic functions in development MM. Results Here, cohort newly diagnosed patients with MM healthy controls (HCs), significant differences metagenomic composition were discovered, first time, higher bacterial diversity Specifically,...

10.1186/s40168-020-00854-5 article EN cc-by Microbiome 2020-05-28

NEK2 is associated with drug resistance in multiple cancers. Our previous studies indicated that high confers inferior survival myeloma (MM); thus, a better understanding of the mechanisms by which induces MM required. In this study, we discovered enhances cell autophagy, and combination autophagy inhibitor chloroquine (CQ) chemotherapeutic bortezomib (BTZ) significantly prevents NEK2-induced cells. Interestingly, was found to bind stabilize Beclin-1 protein but did not affect its mRNA...

10.1002/1878-0261.12641 article EN cc-by Molecular Oncology 2020-01-19

Abstract Metabolites in the tumor microenvironment are a critical factor for progression. However, lack of knowledge about metabolic profile bone marrow (BM) multiple myeloma (MM) limits our understanding MM Here, we show that glycine concentration BM is elevated due to collagen degradation mediated by cell-secreted matrix metallopeptidase 13 (MMP13), while level linked cells utilize channel protein solute carrier family 6 member 9 (SLC6A9) absorb extrinsic subsequently involved synthesis...

10.1038/s41467-022-31248-w article EN cc-by Nature Communications 2022-07-11

Summary The serine synthesis pathway (SSP) is active in multiple cancers. Previous study has shown that bortezomib (BTZ) resistance associated with an increase the SSP myeloma (MM) cells; however, underlying mechanisms of SSP‐induced BTZ remain unclear. In this study, we found phosphoglycerate dehydrogenase (PHGDH), first rate‐limiting enzyme SSP, was significantly elevated CD138 + cells derived from patients relapsed MM. Moreover, high PHGDH conferred inferior survival We also...

10.1111/bjh.16503 article EN British Journal of Haematology 2020-02-10

Lung is colonized by a diverse array of microbes and the lung microbiota profoundly involved in development respiratory diseases. There little knowledge about role dysbiosis cancer. In this study, we performed metagenomic sequencing on bronchoalveolar lavage (BAL) from two different sampling methods non-small cell cancer (NSCLC) patients non-cancer controls. We found obvious variation between bronchoscopy samples lobectomy samples. Oral taxa can be both higher abundance oral Although NSCLC...

10.1038/s41598-021-91195-2 article EN cc-by Scientific Reports 2021-06-03

Abstract Thrombocytopenia is a major complication in subset of patients with multiple myeloma (MM). However, little known about its development and significance during MM. Here, we show thrombocytopenia linked to poor prognosis In addition, identify serine, which released from MM cells into the bone marrow microenvironment, as key metabolic factor that suppresses megakaryopoiesis thrombopoiesis. The impact excessive serine on mainly mediated through suppression megakaryocyte (MK)...

10.1038/s41467-023-37699-z article EN cc-by Nature Communications 2023-04-13

Abstract Nasopharyngeal carcinoma (NPC) has the highest rate of metastasis among head and neck cancers, distant is major reason for treatment failure. We have previously shown that high cyclooxygenase‐2 (COX‐2) expression associated with a poor prognosis patients NPC inhibits chemotherapy‐induced senescence in cells. In this study, we found COX‐2 was upregulated cancer‐associated fibroblasts (CAFs) derived from by RNA‐Seq. Furthermore, elevated CAF detected survival using...

10.1002/mc.23150 article EN cc-by Molecular Carcinogenesis 2019-12-22

Abstract Although patients with nonalcoholic fatty liver disease have been reported to cardiac dysfunction, and appropriate model has not reported. We established a novel mouse of diet-induced steatohepatitis-related cardiomyopathy evaluated the effect pemafibrate. C57Bl/6 male mice were fed (1) chow diet (C), (2) high-fat, high-cholesterol, high-sucrose, bile acid (NASH diet; N), or (3) N pemafibrate 0.1 mg/kg (NP) for 8 weeks. In liver, macrophage infiltration fibrosis in was observed...

10.1038/s41598-022-06542-8 article EN cc-by Scientific Reports 2022-02-22

Abstract It has been previously shown that (never in mitosis gene A)‐related kinase 2 ( NEK2 ) is upregulated multiple myeloma (MM) and contributes to drug resistance. However, the mechanisms behind this upregulation remain poorly understood. In study, it found amplification of hypermethylation distal CpG islands its promoter correlate strongly with increased expression. Patients have a poor rate survival often exhibit TP53 deletion, which an independent prognostic factor MM. This...

10.1002/advs.202104491 article EN cc-by Advanced Science 2022-01-27

Diabetic cardiomyopathy (DCM) is initially characterized by early diastolic dysfunction, left ventricular remodeling, hypertrophy, and myocardial fibrosis, it eventually clinical heart failure. MicroRNAs (miRNAs), endogenous small noncoding RNAs, play significant roles in diabetes mellitus (DM). However, still largely unknown about the mechanism that links miRNAs development of DCM. Here, we aimed to elucidate underlying potential role microRNA-340-5p DCM db/db mouse, which a commonly used...

10.1155/2022/3182931 article EN cc-by Oxidative Medicine and Cellular Longevity 2022-01-27

The gut microbiome has been found to play a crucial role in the treatment of multiple myeloma (MM), which is still considered incurable due drug resistance. In previous studies, we demonstrated that intestinal nitrogen-recycling bacteria are enriched patients with MM. However, their MM relapse remains unclear. This study highlights specific enrichment Citrobacter freundii (C. freundii) relapsed Through fecal microbial transplantation experiments, demonstrate C. plays critical inducing...

10.1016/j.cmet.2023.11.019 article EN cc-by-nc-nd Cell Metabolism 2023-12-18

Multiple myeloma (MM) is a plasma cell malignancy characterized by clonal proliferation in the bone marrow (BM). Previously, it was reported that G‑protein‑coupled receptor 4 (LGR4) contributed to early hematopoiesis and associated with poor prognosis patients MM. However, mechanism of homing migration, which critical for MM progression, remains unclear. In present study, counting, cycle BrdU assays were performed evaluate proliferation. Transwell assay Xenograft mouse models migration...

10.3892/ijo.2025.5718 article EN cc-by-nc-nd International Journal of Oncology 2025-01-03

Fasting and postprandial hypertriglyceridemia (PHTG) are caused by the accumulation of triglyceride (TG)-rich lipoproteins their remnants, which have atherogenic effects. Fibrates can improve fasting PHTG; however, reduction remnants is clinically needed to health outcomes. In current study, we investigated effects a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), K-877 (Pemafibrate), on PHTG remnant metabolism.Male C57BL/6J mice were fed high-fat diet (HFD)...

10.5551/jat.39693 article EN Journal of Atherosclerosis and Thrombosis 2017-08-04

Aim: A direct oral anti-coagulant, FXa inhibitor, has been applied to the clinical treatment of myocardial infarction (MI). Experimental studies in mice indicated that inhibitors reduced atherosclerosis and prevented cardiac dysfunction after coronary ligation. These suggested protease-activated receptor (PAR) 2, a major activated FX, may play an important role remodeling.

10.5551/jat.48405 article EN Journal of Atherosclerosis and Thrombosis 2019-03-13

Resistance to radiotherapy and chemotherapy currently represents one of the major reasons for therapeutic failure in nasopharyngeal carcinoma (NPC). However, mechanisms underlying resistance NPC remain unclear. In this study, cell counting assay, cycle assay senescence associated β-galactosidase activity were performed evaluate growth, proliferation senescence, respectively. We found that aberrant expression cyclooxygenase-2 (COX-2) was with a poor outcome recurrance patients NPC. cells,...

10.3892/ijo.2018.4462 article EN cc-by-nc-nd International Journal of Oncology 2018-06-29

Abstract Nasopharyngeal carcinoma (NPC) is a common malignant tumor in southern China and Southeast Asia, but the molecular mechanism of its pathogenesis poorly understood. Our previous work demonstrated that NEK2 overexpressed multiple cancers. However, how involves NPC development remains to be elucidated. In this study, we firstly identified NEK2, located at +1q32‐q33, late event pathogenesis, stage III‐IV paired sequential recurrent patients with by immunohistochemistry. Furthermore,...

10.1002/jcb.27632 article EN cc-by Journal of Cellular Biochemistry 2018-10-08

Abstract Background B-cell CLL/lymphoma 6 member B (BCL6B) operates as a sequence-specific transcriptional repressor within the nucleus, playing crucial roles in various biological functions, including tumor suppression, immune response, stem cell self-renew, and vascular angiogenesis. However, whether BCL6B is involved endothelial (EC) development has remained largely unknown. ETS variant transcription factor 2 (ETV2) well known to facilitate EC differentiation. This study aims determine...

10.1186/s13287-024-03832-y article EN cc-by Stem Cell Research & Therapy 2024-07-29

Non-alcoholic fatty liver disease is strongly associated with obese and type 2 diabetes. It has been reported that an oxidized cholesterol, 7-ketocholesterol (7KC), might cause inflammatory response in macrophages plasma 7KC concentration were higher patients cardiovascular diseases or Therefore, we have decided to test whether small amount of diet induce hepatic steatosis inflammation two types models. We found addition 0.01% either chow (CD, regular 1% cholesterol) western (WD, high fat...

10.3389/fendo.2020.614692 article EN cc-by Frontiers in Endocrinology 2021-03-10

Cardiac remodeling has no established therapies targeting inflammation. CD4+ T-cell subsets have been reported to play significant roles in healing process after ischemic myocardial injury, but their detailed mechanisms of activation remain unknown. To explore immune reactions during cardiac remodeling, we applied a non-surgical model coronary heart disease (CHD) induced by high-fat diet (HFD-CHD) SR-BI−/−/ApoeR61h/h mice. Flow cytometry analyses throughout the period progressive dysfunction...

10.1016/j.yjmcc.2023.01.011 article EN cc-by-nc-nd Journal of Molecular and Cellular Cardiology 2023-02-03

Pneumonia accounts for a significant cause of morbidity and mortality in multiple myeloma (MM) patients. It has been previously shown that intestinal Klebsiella pneumonia (K. pneumonia) enriches MM promotes progression. However, what role the altered gut microbiota plays with remains unknown. Here, we show K. is significantly enriched pneumonia. This links to incidence MM, colonization contributes 5TGM1 mice model. Further targeted metabolomic assays reveal elevated level glutamine, which...

10.3390/cancers14174188 article EN Cancers 2022-08-29
Coming Soon ...